Zhang C, Wu B, Yang H, Yao Z, et al. The validity of neoadjuvant chemotherapy with paclitaxel plus S-1 is not inferior to that of SOX regimen for locally advanced gastric cancer: an observational study. BMC Cancer 2022;22:1223.
PMID: 36443694